1. Home
  2. MMI vs DAWN Comparison

MMI vs DAWN Comparison

Compare MMI & DAWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MMI
  • DAWN
  • Stock Information
  • Founded
  • MMI 1971
  • DAWN 2018
  • Country
  • MMI United States
  • DAWN United States
  • Employees
  • MMI N/A
  • DAWN N/A
  • Industry
  • MMI Real Estate
  • DAWN Biotechnology: Pharmaceutical Preparations
  • Sector
  • MMI Finance
  • DAWN Health Care
  • Exchange
  • MMI Nasdaq
  • DAWN Nasdaq
  • Market Cap
  • MMI 1.4B
  • DAWN 1.3B
  • IPO Year
  • MMI 2013
  • DAWN 2021
  • Fundamental
  • Price
  • MMI $37.83
  • DAWN $12.24
  • Analyst Decision
  • MMI Sell
  • DAWN Strong Buy
  • Analyst Count
  • MMI 1
  • DAWN 7
  • Target Price
  • MMI $30.00
  • DAWN $36.33
  • AVG Volume (30 Days)
  • MMI 95.7K
  • DAWN 1.1M
  • Earning Date
  • MMI 02-14-2025
  • DAWN 02-24-2025
  • Dividend Yield
  • MMI 1.32%
  • DAWN N/A
  • EPS Growth
  • MMI N/A
  • DAWN N/A
  • EPS
  • MMI N/A
  • DAWN N/A
  • Revenue
  • MMI $622,225,000.00
  • DAWN $101,953,000.00
  • Revenue This Year
  • MMI $2.53
  • DAWN N/A
  • Revenue Next Year
  • MMI $25.74
  • DAWN $35.22
  • P/E Ratio
  • MMI N/A
  • DAWN N/A
  • Revenue Growth
  • MMI N/A
  • DAWN N/A
  • 52 Week Low
  • MMI $29.93
  • DAWN $11.13
  • 52 Week High
  • MMI $42.80
  • DAWN $18.07
  • Technical
  • Relative Strength Index (RSI)
  • MMI 53.04
  • DAWN 45.74
  • Support Level
  • MMI $34.72
  • DAWN $11.13
  • Resistance Level
  • MMI $38.07
  • DAWN $12.74
  • Average True Range (ATR)
  • MMI 0.96
  • DAWN 0.51
  • MACD
  • MMI 0.19
  • DAWN 0.06
  • Stochastic Oscillator
  • MMI 83.73
  • DAWN 51.15

About MMI Marcus & Millichap Inc.

Marcus & Millichap Inc is a leading national brokerage firm specializing in commercial real estate investment sales, financing, research, and advisory services. The company offers three primary services to its clients: commercial real estate investment brokerage, financing, and ancillary services, including other research, advisory, and consulting services. The company generates revenues by collecting fees on the sale and financing of commercial properties. These fees consist of commissions collected upon the sale of a property and fees collected from the placement of loans.

About DAWN Day One Biopharmaceuticals Inc.

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, kinase inhibitor.

Share on Social Networks: